Literature DB >> 9762910

Growth factor protection against cytokine-induced apoptosis in neonatal rat islets of Langerhans: role of Fas.

M Harrison1, A M Dunger, S Berg, J Mabley, N John, M H Green, I C Green.   

Abstract

Treatment of neonatal rat islets of Langerhans with combined cytokines (interleukin-1beta 10(-10) M, tumour necrosis factor-alpha 10(-10) M, interferon-gamma 5 U/ml) led to extensive cell death, which was potentiated by Fas activation with the anti-Fas cytolytic antibody JO2. Pre-treatment with insulin (25 ng/ml) or insulin-like growth factor-1 (10(-8)M) gave only partial protection against cell killing, but prevented the Fas-mediated component. In the absence of cytokine treatment, Fas-mediated killing was not observed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9762910     DOI: 10.1016/s0014-5793(98)01051-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Effects of tyrosine kinase inhibitors on cell death induced by sodium fluoride and pertussis toxin in the pancreatic beta-cell line, RINm5F.

Authors:  J Elliott; J H Scarpello; N G Morgan
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Signaling cross talk between growth hormone (GH) and insulin-like growth factor-I (IGF-I) in pancreatic islet β-cells.

Authors:  Fanxin Ma; Zhe Wei; Chunwei Shi; Yan Gan; Jia Lu; Stuart J Frank; James Balducci; Yao Huang
Journal:  Mol Endocrinol       Date:  2011-10-27

3.  Nitric oxide contributes to cytokine-induced apoptosis in pancreatic beta cells via potentiation of JNK activity and inhibition of Akt.

Authors:  J Størling; J Binzer; A K Andersson; R A Züllig; M Tonnesen; R Lehmann; G A Spinas; S Sandler; N Billestrup; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  2005-08-25       Impact factor: 10.122

4.  Beta cell expression of IGF-I leads to recovery from type 1 diabetes.

Authors:  Mónica George; Eduard Ayuso; Alba Casellas; Cristina Costa; Jean Christophe Devedjian; Fatima Bosch
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.